Starling Oncology Institute Inc (STLN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2023 | 09-2023 | 06-2023 | 03-2023 | 12-2022 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -83,068 | -64,314 | -46,895 | -29,998 | 152 |
| Depreciation Amortization | 26,314 | 25,084 | 20,943 | 18,739 | 15,779 |
| Income taxes - deferred | -76 | 50 | -30 | -26 | -263 |
| Accounts receivable | -4,564 | -8,657 | -6,576 | -6,141 | -20,285 |
| Accounts payable and accrued liabilities | 5,057 | 3,961 | 3,751 | 2,574 | -6,187 |
| Other Working Capital | 2,359 | -4,087 | -2,976 | -4,777 | -20,541 |
| Other Operating Activity | 17,663 | 15,541 | 7,671 | 4,177 | -30,411 |
| Operating Cash Flow | $-36,315 | $-32,422 | $-24,112 | $-15,452 | $-61,756 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -4,567 | -3,706 | -2,776 | -1,839 | -5,529 |
| Net Acquisitions | -4,456 | -4,300 | -4,300 | N/A | -8,577 |
| Purchase Of Investment | -9,595 | -9,683 | -9,747 | -9,759 | -117,508 |
| Sale Of Investment | 81,258 | 68,702 | 60,127 | 29,999 | N/A |
| Investing Cash Flow | $62,640 | $51,013 | $43,304 | $18,401 | $-131,614 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | N/A | N/A | N/A | N/A | 110,000 |
| Debt Repayment | -101 | -91 | -81 | -18 | -58 |
| Common Stock Issued | 126 | 13 | 0 | 0 | 858 |
| Common Stock Repurchased | -1,019 | -1,019 | -894 | N/A | -9,000 |
| Other Financing Activity | -5,853 | -3,969 | -3,335 | -1,691 | -9,594 |
| Financing Cash Flow | $-6,847 | $-5,066 | $-4,310 | $-1,709 | $92,206 |
| Beginning Cash Position | 14,010 | 14,010 | 14,010 | 14,010 | 115,174 |
| End Cash Position | 33,488 | 27,535 | 28,892 | 15,250 | 14,010 |
| Net Cash Flow | $19,478 | $13,525 | $14,882 | $1,240 | $-101,164 |
| Free Cash Flow | |||||
| Operating Cash Flow | -36,315 | -32,422 | -24,112 | -15,452 | -61,756 |
| Capital Expenditure | -4,567 | -3,706 | -2,776 | -1,839 | -5,529 |
| Free Cash Flow | -40,882 | -36,128 | -26,888 | -17,291 | -67,285 |